Cancer medicines remain absent from global access metrics

The Lancet 2026

View at publisher

Authors: Kristina Jenei, Richard Sullivan

DOI: 10.1016/s0140-6736(25)02501-2

Cited by: 1

References: 2

Fields of Study & Subjects

Pharmaceutical Economics and Policy Economic and Financial Impacts of Cancer Pharmaceutical Quality and Counterfeiting

References 2